Patents by Inventor Anthony S. Drager

Anthony S. Drager has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150274675
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: November 12, 2013
    Publication date: October 1, 2015
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • Publication number: 20150246023
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: May 13, 2015
    Publication date: September 3, 2015
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • Publication number: 20150232427
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: April 29, 2015
    Publication date: August 20, 2015
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • Publication number: 20140206733
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: March 21, 2014
    Publication date: July 24, 2014
    Applicant: Cephalon, Inc.
    Inventors: Anthony S. Drager, Rachel Y. Labell, Piyush R. Patel
  • Publication number: 20140128443
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: January 9, 2014
    Publication date: May 8, 2014
    Applicant: Cephalon, Inc.
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel
  • Publication number: 20140080881
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: November 20, 2013
    Publication date: March 20, 2014
    Applicant: Cephalon, Inc.
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel
  • Publication number: 20130041004
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: October 19, 2012
    Publication date: February 14, 2013
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel
  • Patent number: 8344006
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Grant
    Filed: January 31, 2012
    Date of Patent: January 1, 2013
    Assignee: Cephalon, Inc.
    Inventors: Anthony S. Drager, Rachel Y. Labell, Piyush R. Patel
  • Publication number: 20120129904
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: January 31, 2012
    Publication date: May 24, 2012
    Applicant: CEPHALON, INC.
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel
  • Publication number: 20110190363
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: March 15, 2011
    Publication date: August 4, 2011
    Applicant: CEPHALON, INC.
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel
  • Publication number: 20090155352
    Abstract: The invention described herein provides a pharmaceutical composition and oral dosage forms containing the same, having high concentrations of solubilized indolocarbazole compounds as the active ingredient in microemulsion form. The invention also provides a process for increasing the solubilized concentration of indolocarbazole compounds such as lestaurtinib using the addition of water in combination with a hydrophilic component as part of the microemulsion formation process.
    Type: Application
    Filed: November 20, 2008
    Publication date: June 18, 2009
    Applicant: Cephalon, Inc.
    Inventors: Anthony S. Drager, Bradley T. Mclntyre, Piyush R. Patel
  • Patent number: 7056496
    Abstract: The present invention includes a process of preparing an advanced cosmetic product by combining a high internal phase ratio (HIPR) emollient-in-water emulsion with a partial cosmetic formulation that typically contains water, a coloring agent, a fragrance, a rheology modifier, or a pH adjuster, or a combination thereof. The present invention also includes compositions directed to two particular subclasses of HIPR emollient-in-water emulsions, namely an HIPR silicone elastomer-in-water emulsion and an HIPR sunscreen-in-water emulsion and water-diluted dispersions thereof. The use of an HIPR emulsion of a cosmetic emollient provides a simple and flexible method of formulating the cosmetic product, due in part to the long shelf-stability of the HIPR emulsion (greater than 1 year), and the low quantity of water in the emulsion (typically less than 20% by volume based on the volume of emollient and water).
    Type: Grant
    Filed: February 21, 2003
    Date of Patent: June 6, 2006
    Assignee: Dow Global Technologies Inc.
    Inventors: James E. Pate, Dale C. Schmidt, David L. Malotky, Anthony S. Drager, Letha M. Gatz, Christian Piechocki
  • Patent number: 6783766
    Abstract: The present invention is a process of preparing an advanced cosmetic product by combining a high internal phase ratio (HIPR) emollient-in-water emulsion with a partial cosmetic formulation that typically contains water, fragrance, a rheology modifier, or a pH adjuster, or a combination thereof. The present invention is also a composition comprising two particular subclasses of HIPR emollient-in-water emulsions, namely an HIPR silicone elastomer-in-water emulsion and an HIPR sunscreen-in-water emulsion. The use of an HIPR emulsion of a cosmetic emollient provides a simple and flexible method of formulating the cosmetic product, due in part to the long shelf-stability of the HIPR emulsion (>1 year), and the low quantity of water in the emulsion (typically less than 20% by volume based on the volume of emollient and water).
    Type: Grant
    Filed: March 6, 2002
    Date of Patent: August 31, 2004
    Assignee: Dow Global Technologies Inc.
    Inventors: James E. Pate, Dale C. Schmidt, David L. Malotky, Anthony S. Drager, Christian Piechocki
  • Publication number: 20030175316
    Abstract: The present invention includes a process of preparing an advanced cosmetic product by combining a high internal phase ratio (HIPR) emollient-in-water emulsion with a partial cosmetic formulation that typically contains water, a coloring agent, a fragrance, a rheology modifier, or a pH adjuster, or a combination thereof. The present invention also includes compositions directed to two particular subclasses of HIPR emollient-in-water emulsions, namely an HIPR silicone elastomer-in-water emulsion and an HIPR sunscreen-in-water emulsion and water-diluted dispersions thereof. The use of an HIPR emulsion of a cosmetic emollient provides a simple and flexible method of formulating the cosmetic product, due in part to the long shelf-stability of the HIPR emulsion (greater than 1 year), and the low quantity of water in the emulsion (typically less than 20% by volume based on the volume of emollient and water).
    Type: Application
    Filed: February 21, 2003
    Publication date: September 18, 2003
    Inventors: James E. Pate, Dale C. Schmidt, David L. Malotky, Anthony S. Drager, Letha M. Gatz, Christian Piechocki
  • Publication number: 20030170193
    Abstract: The present invention is a process of preparing an advanced cosmetic product by combining a high internal phase ratio (HIPR) emollient-in-water emulsion with a partial cosmetic formulation that typically contains water, fragrance, a rheology modifier, or a pH adjuster, or a combination thereof. The present invention is also a composition comprising two particular subclasses of HIPR emollient-in-water emulsions, namely an HIPR silicone elastomer-in-water emulsion and an HIPR sunscreen-in-water emulsion. The use of an HIPR emulsion of a cosmetic emollient provides a simple and flexible method of formulating the cosmetic product, due in part to the long shelf-stability of the HIPR emulsion (>1 year), and the low quantity of water in the emulsion (typically less than 20% by volume based on the volume of emollient and water).
    Type: Application
    Filed: March 6, 2002
    Publication date: September 11, 2003
    Inventors: James E. Pate, Dale C. Schmidt, David L. Malotky, Anthony S. Drager, Christian Piechocki